Why is RNAC Down Today?
About Cartesian Therapeutics, Inc. Common Stock
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platf...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for RNAC's -6% move
No Options Available
RNAC doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get RNAC Alerts
We'll notify you when RNAC's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
RNAC has moved more than 3.0% down on 55 occasions in the past year.
Frequently Asked Questions
Why is RNAC stock down today?
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is RNAC stock a buy or sell right now?
Based on current analysis, RNAC shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the RNAC stock price target?
RNAC is currently trading at $6.50. Based on today's momentum, the expected short-term range is $6.30 - $6.63. See long-term price prediction →
Will RNAC stock continue falling?
Our analysis shows a 45% probability that RNAC's move continues in the next 1-3 days. Key level to watch: $6.17 (support).
Is RNAC stock oversold or overbought?
RNAC's RSI (Relative Strength Index) is currently at 44.4. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for RNAC stock?
RNAC's 10-day momentum indicator is at -0.25. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is RNAC outperforming or underperforming the market?
RNAC (-5.52%) is currently significantly underperforming the market (-5.2% vs SPY). Today, the S&P 500 (SPY) is down -0.33%, and Nasdaq (QQQ) is down -0.41%.
What does MACD indicate for RNAC?
RNAC's MACD (-0.08) is currently above the signal line (-0.15), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 16.8) is weak.
Is RNAC in an uptrend or downtrend?
Based on moving average analysis, RNAC is in a bearish trend. The price ($6.50) is trading below both the 20-day SMA ($6.58) and 50-day SMA ($7.2). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis